Skip to main content
. 2023 Mar 30;6(3):e236086. doi: 10.1001/jamanetworkopen.2023.6086

Table 1. Outcome Measures by Condition and Time Point for Treatment Outcomes.

Outcome measure Marginal mean (95% CI)
Baseline After module 1 After intervention Follow-up
PTSD symptoms
METRA 41.93 (40.07-43.78) 35.59 (33.35-37.84) 24.27 (21.82-26.71) 23.27 (20.16-26.39)
TAU 44.40 (42.19-46.61) 43.06 (40.13-45.98) 41.13 (38.98-44.28) 37.28 (33.87-40.69)
Depression symptoms
METRA 17.78 (16.56-18.97) 13.64 (12.03-15.24) 11.04 (9.24-12.83) 11.65 (9.78-13.53)
TAU 17.11 (15.44-18.78) 18.55 (16.80-20.28) 17.77 (16.02-19.49) 16.57 (14.66-18.48)
SDQ difficulties
METRA 18.55 (17.38-19.72) 16.96 (15.56-18.36) 13.96 (12.48-15.45) 12.93 (11.09-14.78)
TAU 18.76 (17.35-20.16) 19.77 (18.42-21.11) 19.01 (17.80-20.22) 19.38 (17.75-21.01)
Afghan-culture specific symptoms
METRA 49.58 (46.15-53.00) 37.61 (33.59-41.62) 31.93 (27.62-36.25) 35.20 (30.72-39.68)
TAU 49.36 (44.61-54.10) 51.29 (46.95-55.63) 47.78 (43.50-52.06) 46.97 (41.79-52.15)
Anxiety
METRA 26.20 (25.30-27.10) 22.98 (21.92-24.03) 21.50 (20.26-22.74) 20.98 (19.21-22.75)
TAU 26.22 (25.15-27.30) 26.12 (24.70-27.55) 26.66 (25.44-27.88) 25.17 (23.67-26.68)

Abbreviations: METRA, Memory Training for Recovery–Adolescent; PTSD, posttraumatic stress disorder; SDQ, Strengths and Difficulties Questionnaire; TAU, treatment as usual.